DETERMINANTS OF ATHEROSCLEROSIS IN CAPD PATIENTS - ROLE OF APOPROTEIN (A) ISOFORM, LIPOPROTEIN(A) AND FIBRINOGEN SERUM LEVELS

被引：0
|
作者：
BARTENS, W [1 ]
NAUCK, M [1 ]
SCHOLLMEYER, P [1 ]
WANNER, C [1 ]
机构：
[1] UNIV CLIN FREIBURG,DEPT MED,FREIBURG,GERMANY
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1994年 / 5卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [1] DETERMINANTS OF ATHEROSCLEROSIS IN CAPD PATIENTS - ROLE OF APOPROTEIN(A) ISOFORM, LIPOPROTEIN(A) AND FIBRINOGEN SERUM LEVELS
    BARTENS, W
    NAUCK, M
    SCHOLLMEYER, P
    WANNER, C
    KIDNEY INTERNATIONAL, 1995, 47 (03) : 965 - 965
  • [2] Chlamydia pneumonia seropositivity correlates with serum fibrinogen and lipoprotein a levels:: Any role in atherosclerosis?
    Tütüncü, NB
    Güvener, N
    Tütüncü, T
    Yilmaz, M
    Güvener, M
    Böke, E
    Pasaoglu, I
    Erbas, T
    ENDOCRINE JOURNAL, 2001, 48 (02) : 269 - 274
  • [3] Fibrinogen and fibrinolytic activity in CAPD patients with atherosclerosis and its correlation with serum albumin
    Kim, KJ
    Yang, WS
    Kim, SB
    Lee, SK
    Park, JS
    PERITONEAL DIALYSIS INTERNATIONAL, 1997, 17 (02): : 157 - 161
  • [4] Determinants of serum fibrinogen levels in Maltese patients with NIDDM
    Schranz, A
    Tuomilehto, J
    Laine, A
    Karvonen, M
    DIABETOLOGIA, 1997, 40 : 1601 - 1601
  • [5] THE ROLE OF LP(A) LEVELS AND APOPROTEIN(A PHENOTYPE IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN PATIENTS WITH CAD
    Labudovic, D. D.
    Trajkovska, K. N. Toseska
    Alabakovska, S. B.
    Bogdanska, J. J.
    Todorova, B. B.
    Jovanova, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 175 - 176
  • [6] Association of plasma fibrinogen with serum lipoprotein(a) levels
    Kovesdy, C
    Astor, B
    Coresh, J
    CIRCULATION, 2003, 107 (07) : E7025 - E7025
  • [7] Effects of atorvastatin 10 mg on serum lipoprotein and fibrinogen levels in hypercholesterolemic patients
    Branchi, A
    Rovellini, A
    Fiorenza, AM
    Muzio, F
    Torri, A
    Sommariva, D
    ATHEROSCLEROSIS, 1999, 144 : 184 - 184
  • [8] SERUM LIPOPROTEIN LEVELS DURING 2 TO 5 YEARS ON CAPD
    NORBECK, HE
    LINDHOLM, B
    PERITONEAL DIALYSIS BULLETIN, 1985, 5 (01): : 88 - 88
  • [9] The role of Lp(a) levels and apoprotein(a) phenotype in the development of atherosclerosis in patients with coronary artery disease
    Labudovic, D. D.
    Trajkovska, K. N. Toseska
    Alabakovska, S. B.
    Todorova, B. B.
    Jovanova, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 70 - 70
  • [10] THE ROLE OF LP(A) LEVELS AND APOPROTEIN(A) PHENOTYPE IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN PATIENTS WITH CORONARY ARTERY DISEASE
    Labudovic, D.
    Toseska-Trajkovska, K.
    Alabakovska, S.
    Bogdanska, J.
    Jovanova, S.
    ATHEROSCLEROSIS, 2016, 252 : E126 - E126
12345